October 01, 2014 10:37 AM ET

Biotechnology

Company Overview of Civitas Therapeutics, Inc.

Key Executives for Civitas Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Mark Iwicki 39 RelationshipsChief Executive Officer, President and Director47
Glenn V. Batchelder 15 RelationshipsCo-Founder and Director52
Richard Batycky Ph.D.No RelationshipsCo-Founder and Chief Scientific Officer--
Jeff Elton 1 RelationshipsCo-Founder--
Martin Freed M.D.No RelationshipsCo-Founder and Chief Medical Officer--
View More Key Executives

Civitas Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Timothy S. Nelson 24 RelationshipsMAP Pharmaceuticals, Inc.50
Mark Iwicki 39 RelationshipsCivitas Therapeutics, Inc.47
Glenn V. Batchelder 15 RelationshipsCivitas Therapeutics, Inc.52
James L. Wright Ph.D. 15 RelationshipsCivitas Therapeutics, Inc.66
David J. Hirsch M.D., Ph.D. 50 RelationshipsLongitude Capital Management Co., LLC--
View All Board Members

Civitas Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.James L. Wright15 Relationships6 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
363.6K
Bonus
215.3K
Total Short Term Compensation
437.6K
Total Value of Options
21.7M
Compensation as of Fiscal Year
Civitas Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Ryan Continues European Expansion with Opening of New Office in Paris, France; Jean-Paul Ouaksel Hires as Principal to Lead French Practice
September 29, 2014 2:30 PM ET
Hindustan Unilever Limited Announces Key Changes in the Management Committee, Effective November 2014
September 26, 2014 10:30 AM ET
P&G Vice Chairman and Special Advisor to the Chairman and Chief Executive Officer Werner Geissler to Retire
September 24, 2014 1:30 PM ET
The Clorox Company Announces Executive Changes
September 23, 2014 12:30 PM ET
The Clorox Company Announces Executive Changes, Effective November 20, 2014
September 23, 2014 11:57 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Civitas Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.